In vitro study of rat prostate 5α-reductase activity and its inhibition
- 31 Downloads
- 3 Citations
Abstract
A simple and rapid method of measuring 5α-reductase (5α-R) activity and of determining the kinetic parameters (KM and Vmax) of the enzyme is described. The 5α-R activity in the homogenate of the prostate of Wistar rats aged 8–12 weeks was established, and the effects of natural and synthetic steroids and of non-steroidal antiandrogens (IC50) upon the 5α-R activity were studied. Of the natural steroids, 17-0H-progesterone was found to have the highest inhibitory effect (IC50=1.35 μM), followed in decreasing order by progesterone (IC50=5.0 μM) and 4-androstene-3,17-dione (IC50=21.6 μM). Oestradiol-17β had practically no inhibitory effect. Of the synthetic steroids, 4-MA had the highest inhibitory effect (IC50=0.068 μM), followed by nortestosterone (IC50=7.4 μM) and RU-486 (Mifepristone) (IC50=115 μM). Even at 1000 μM, cyproterone acetate exerted no inhibitory effect. Of the nonsteroidal compounds, ketoconazole proved a weak inhibitor (IC50=115 μM), while flutamide was practically ineffective.
Keywords
Testosterone International Urology Flutamide Mifepristone Cyproterone AcetatePreview
Unable to display preview. Download preview PDF.
References
- 1.Bingham, K. D., Shaw, D. A.: The metabolism of testosterone by human male scalp skin.J. Endocrinol., 57, 111 (1973).PubMedCrossRefGoogle Scholar
- 2.Blohm, T. R., Laughlin, M. E., Benson, H. D., Johnston, J. O., Wright, C. L., Schatzman, G. L., Weintraub, C. M.: Pharmacological induction of 5α-reductase deficiency in the rat: Separation of testosterone-mediated and 5α-dihydrotestosterone-mediated effects.Endocrinology 119, 959 (1986).PubMedGoogle Scholar
- 3.Bruchovsky, N., Wilson, J. D.: The conversion of testosterone to 5α-androstan-17β-ol-3-one by rat prostate in vivo and in vitro.J. Biol. Chem., 243, 2012 (1968).PubMedGoogle Scholar
- 4.Bruchovsky, N., Wilson, J. D.: The intranuclear binding of testosterone and 5α-androstan-17β-ol-3-one by rat prostate.J. Biol. Chem., 243, 5953 (1968).PubMedGoogle Scholar
- 5.George, F. W., Peterson, K. G.: 5α-Dihydrotestosterone formation is necessary for embryogenesis of the rat prostate.Endocrinology 122, 1159 (1988).PubMedGoogle Scholar
- 6.Imperato-McGinley, J., Binienda, Z., Arthur, A., Minenberg, D. T., Vaugham, E. D., Quimley, F. W.: The development of the male pseudohermaphrodite rat using an inhibitor of the enzyme 5α-reductase.Endocrinology, 116, 807 (1985).PubMedGoogle Scholar
- 7.Julesz, M., Faredin, I., Tóth, I.: Steroids in Human Skin. Akadémiai Kiadó, Budapest 1971, p. 166.Google Scholar
- 8.Kadohama, N., Wakisaka, M., Kinn, U., Karr, J. P., Murphy, G. P., Sandberg, A. A.: Retardation of prostate tumor progression in the Noble rat by 4-methyl-4-aza-steroidal inhibitors of 5α-reductase.J. Natl. Cancer Inst., 71, 475 (1985).Google Scholar
- 9.Liang, T., Cascieri, M. A., Cheung, A. H., Reynolds, G. F., Rasmusson, G. H.: Species differences in prostatic steroid 5α-reductases of rat, dog and human.Endocrinology, 117, 571 (1985).PubMedGoogle Scholar
- 10.Lowry, O. H., Rosenbrough, N. J., Farr, A. L., Randall, R. J.: Protein measurement with the Folin Phenol reagent.J. Biol. Chem., 193, 265 (1951).PubMedGoogle Scholar
- 11.Metcalf, B. W., Levy, M. A., Holt, D. A.: Inhibitors of steroid 5α-reductase in benign prostatic hyperplasia, male pattern baldness and acne. TiPS10, 491 (1989).PubMedGoogle Scholar
- 12.Metcalf, B. W., Holt, D. A., Levy, M. A., Erb, J. M., Heaslip, J. J., Barndt, M., Oh, H.-J.: Potent inhibition of human steroid 5α-reductase (EC 1.3.1.30.) by 3-androstene-3-carboxylic acids.Bioorg. Chem. 17, 372 (1989).CrossRefGoogle Scholar
- 13.Sansone, G., Reisner, R. M.: Differential rates of conversion of testosterone to dihydrotestosterone in acne and normal human skin—a possible pathogenic factor in acne.J. Invest. Dermatol., 56, 366 (1971).PubMedCrossRefGoogle Scholar
- 14.Schultz, F. M., Wilson, J. D.: Virilization of the Wolffian duct in the rat fetus by various androgens.Endocrinology, 94, 979 (1974).PubMedCrossRefGoogle Scholar
- 15.Shimazaki, J., Kurihara, H., Ito, G., Shida, K.: Testosterone metabolism in prostate; formation of androstan-17β-ol-3-one and androst-4-ene-3,17-dione, and inhibitory effect of natural and synthetic estrogens.Gumma J. Med. Sci., 14, 313 (1965).Google Scholar
- 16.Waller, D. P., Martin, A., Vickery, B. H., Zaneveld, L. J. D.: The effect of ketoconazole on fertility of male rats.Contraception, 41, 411 (1990).PubMedCrossRefGoogle Scholar
- 17.Wenderoth, U. K., George, F. W., Wilson, J. D.: The effect of a 5α-reductase inhibitor on androgen-mediated growth of the dog prostate.Endocrinology, 113, 569 (1983).PubMedGoogle Scholar
- 18.Wilson, J. D.: The pathogenesis of benign prostatic hyperplasia.Am. J. Med., 68, 745 (1980).PubMedCrossRefGoogle Scholar
- 19.Wilson, J. D., Lasnitzki, J.: Dihydrotestosterone formation in fetal tissues of the rabbit and rat.Endocrinology, 89, 659 (1971).PubMedCrossRefGoogle Scholar